Blueprint Medicines Corp
F:2L9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Blueprint Medicines Corp
F:2L9
|
US |
|
C
|
Chiyoda Corp
F:CYA
|
JP |
|
B
|
Bambuser AB
XMUN:5JL
|
SE |
|
S
|
Scandinavian Real Heart AB
F:782
|
SE |
|
Japan Engine Corp
OTC:KDCLF
|
JP |
|
Chakana Copper Corp
OTC:CHKKD
|
CA |
|
Digital Hearts Holdings Co Ltd
F:957
|
JP |
|
Dril-Quip Inc
NYSE:INVX
|
US |
|
Molecule Holdings Inc
F:ERV2
|
CA |
|
F
|
First Foundation Inc
F:8F1
|
US |
|
Atresmedia Corporacion de Medios de Comunicacion SA
F:YT2
|
ES |
|
Colonial Coal International Corp
F:COX
|
CA |
|
Maple Gold Mines Ltd
F:M3G0
|
CA |
|
S
|
Stabilus SE
SWB:STM
|
DE |
|
B
|
Benchmark Metals Inc
F:87CA
|
CA |
Shareholder Yield
Current shareholder yield for 
2L9 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
2L9 Price
Blueprint Medicines Corp
| Average Annual Return | 23.22% |
| Standard Deviation of Annual Returns | 82.49% |
| Max Drawdown | -64% |
| Market Capitalization | 8.4B EUR |
| Shares Outstanding | 62 620 000 |
| Percentage of Shares Shorted |
N/A
|
